Skip to main navigation Skip to search Skip to main content

Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia

  • Cathryn M. Lewis
  • , Douglas F. Levinson
  • , Lesley H. Wise
  • , Lynn E. DeLisi
  • , Richard E. Straub
  • , Iiris Hovatta
  • , Nigel M. Williams
  • , Sibylle G. Schwab
  • , Ann E. Pulver
  • , Stephen V. Faraone
  • , Linda M. Brzustowicz
  • , Charles A. Kaufmann
  • , David L. Garver
  • , Hugh M.D. Gurling
  • , Eva Lindholm
  • , Hilary Coon
  • , Hans W. Moises
  • , William Byerley
  • , Sarah H. Shaw
  • , Andrea Mesen
  • Robin Sherrington, F. Anthony O'Neill, Dermot Walsh, Kenneth S. Kendler, Jesper Ekelund, Tiina Paunio, Jouko Lönnqvist, Leena Peltonen, Michael C. O'Donovan, Michael J. Owen, Dieter B. Wildenauer, Wolfgang Maier, Gerald Nestadt, Jean Louis Blouin, Stylianos E. Antonarakis, Bryan J. Mowry, Jeremy M. Silverman, Raymond R. Crowe, C. Robert Cloninger, Ming T. Tsuang, Dolores Malaspina, Jill M. Harkavy-Friedman, Dragan M. Svrakic, Anne S. Bassett, Jennifer Holcomb, Gursharan Kalsi, Andrew McQuillin, Jon Brynjolfson, Thordur Sigmundsson, Hannes Petursson, Elena Jazin, Tomas Zoëga, Tomas Helgason
  • King's College London
  • University of Pennsylvania
  • New York University
  • National Institutes of Health
  • National Institute for Health and Welfare
  • Cardiff University
  • University of Bonn
  • Johns Hopkins University
  • Rutgers - The State University of New Jersey, New Brunswick
  • Columbia University
  • University of Louisville
  • University College London
  • Uppsala University
  • University of Utah
  • Universitätsklinikum Kiel
  • University of California at Irvine
  • DNA Sciences, Inc.
  • Hospital Nacional Psiquiatrico
  • Xenon Genetics
  • Queen's University Belfast
  • Health Research Board Ireland
  • Virginia Commonwealth University
  • University of Helsinki
  • University of California at Los Angeles
  • University of Geneva
  • Queensland Health
  • University of Queensland
  • Icahn School of Medicine at Mount Sinai
  • University of Iowa
  • Washington University St. Louis
  • Massachusetts Department of Mental Health
  • University of Toronto
  • General Hospital
  • Landspitali University Hospital

Research output: Contribution to journalArticlepeer-review

1003 Scopus citations

Abstract

Schizophrenia is a common disorder with high heritability and a 10-fold increase in risk to siblings of probands. Replication has been inconsistent for reports of significant genetic linkage. To assess evidence for linkage across studies, rank-based genome scan meta-analysis (GSMA) was applied to data from 20 schizophrenia genome scans. Each marker for each scan was assigned to 1 of 120 30-cM bins, with the bins ranked by linkage scores (1 = most significant) and the ranks averaged across studies (Ravg) and then weighted for sample size (√N[affected cases]). A permutation test was used to compute the probability of observing, by chance, each bin's average rank (PAvgRnk) or of observing it for a bin with the same place (first, second, etc.) in the order of average ranks in each permutation (Pord). The GSMA produced significant genomewide evidence for linkage on chromosome 2q (PAvgRnk < .000417). Two aggregate criteria for linkage were also met (clusters of nominally significant P values that did not occur in 1,000 replicates of the entire data set with no linkage present): 12 consecutive bins with both PAvgRnk and Pord < .05, including regions of chromosomes 5q, 3p, 11q, 6p, 1q, 22q, 8p, 20q, and 14p, and 19 consecutive bins with Pord < .05, additionally including regions of chromosomes 16q, 18q, 10p, 15q, 6q, and 17q. There is greater consistency of linkage results across studies than has been previously recognized. The results suggest that some or all of these regions contain loci that increase susceptibility to schizophrenia in diverse populations.

Original languageEnglish
Pages (from-to)34-48
Number of pages15
JournalAmerican Journal of Human Genetics
Volume73
Issue number1
DOIs
StatePublished - Jul 1 2003

Fingerprint

Dive into the research topics of 'Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia'. Together they form a unique fingerprint.

Cite this